S.C. Code Ann. § 44-137-30
No liability to heirs for outstanding debt related to treatment with investigational drug, biological product, or device
Effective Jun 3, 20162016 Act No. 230 (H.4542), SECTION 2, eff June 3, 2016.
If an eligible patient dies while being treated with an investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatment.
HISTORY: 2016 Act No. 230 (H.4542), SECTION 2, eff June 3, 2016.